| Previous close | 194.21 |
| Open | 194.12 |
| Bid | 167.20 |
| Ask | 175.50 |
| Strike | 100.00 |
| Expiry date | 2023-06-16 |
| Day's range | 194.12 - 194.21 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
- Motley Fool
Should You Buy Biogen Before a Big July Decision?
Over time, Biogen (NASDAQ: BIIB) created a true success story. Competition for Biogen's MS blockbuster Tecfidera, and for other key products, entered the market. Now, though, Biogen may have found that new growth source.
- Zacks
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Is There An Opportunity With Biogen Inc.'s (NASDAQ:BIIB) 27% Undervaluation?
Key Insights The projected fair value for Biogen is US$362 based on 2 Stage Free Cash Flow to Equity Biogen's US$265...
© 2023 Yahoo. All rights reserved.
